EUR 306.0
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 3.39 Million EUR | -19.2% |
2022 | 4.2 Million EUR | 6.57% |
2021 | 3.94 Million EUR | 667.98% |
2020 | -694.41 Thousand EUR | 15.83% |
2019 | -825.03 Thousand EUR | 43.52% |
2018 | -1.46 Million EUR | -16.59% |
2017 | -1.25 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 1.82 Million EUR | 0.0% |
2023 FY | 3.39 Million EUR | -19.2% |
2023 Q2 | 949.99 Thousand EUR | 0.0% |
2023 Q4 | 2.44 Million EUR | 0.0% |
2022 Q2 | 1.91 Million EUR | 0.0% |
2022 FY | 4.2 Million EUR | 6.57% |
2022 Q4 | 2.29 Million EUR | 0.0% |
2021 FY | 3.94 Million EUR | 667.98% |
2021 Q4 | 2.39 Million EUR | 0.0% |
2021 Q2 | 1.55 Million EUR | 0.0% |
2020 FY | -694.41 Thousand EUR | 15.83% |
2020 Q4 | -48.82 Thousand EUR | 0.0% |
2020 Q2 | -645.59 Thousand EUR | 0.0% |
2019 Q4 | -309.58 Thousand EUR | 0.0% |
2019 Q2 | -515.45 Thousand EUR | 0.0% |
2019 FY | -825.03 Thousand EUR | 43.52% |
2018 Q4 | -154.5 Thousand EUR | 0.0% |
2018 FY | -1.46 Million EUR | -16.59% |
2018 Q3 | -154.5 Thousand EUR | 73.17% |
2018 Q1 | -575.9 Thousand EUR | -57.69% |
2018 Q2 | -575.9 Thousand EUR | 0.0% |
2017 Q4 | -365.2 Thousand EUR | 0.0% |
2017 Q1 | -313.25 Thousand EUR | 0.0% |
2017 FY | -1.25 Million EUR | 0.0% |
2017 Q2 | -313.25 Thousand EUR | 0.0% |
2016 Q4 | -313.25 Thousand EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Fresenius Medical Care AG & Co. KGaA | 498.99 Million EUR | 99.319% |
Fresenius SE & Co. KGaA | -594 Million EUR | 100.572% |
M1 Kliniken AG | 10.27 Million EUR | 66.942% |
Maternus-Kliniken Aktiengesellschaft | -14.25 Million EUR | 123.823% |
MEDICLIN Aktiengesellschaft | -10.77 Million EUR | 131.519% |
RHÖN-KLINIKUM Aktiengesellschaft | 38.71 Million EUR | 91.226% |
VITA 34 AG | -1.86 Million EUR | 282.117% |